![](https://investorshub.advfn.com/uicon/686292.png?cb=1588582332)
Monday, March 23, 2020 11:32:52 AM
They no longer have that board member who brought only financial expertise, who did not agree with the strategy moving forward. It was not stated by the company what that strategy was.
It was postulated that he preferred the stem cell business model to going after alternative revenue streams. No proof of that. Meaningless as the company is still more than capable to do anything stem cell related they choose.
Long term the real money remains in women's health, database, oncology, etc...but to benefit from saving lives during a public health crisis (if happening) is not a negative.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM